1. Home
  2. VERB vs OGEN Comparison

VERB vs OGEN Comparison

Compare VERB & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERB
  • OGEN
  • Stock Information
  • Founded
  • VERB 2014
  • OGEN 1996
  • Country
  • VERB United States
  • OGEN United States
  • Employees
  • VERB N/A
  • OGEN N/A
  • Industry
  • VERB Other Consumer Services
  • OGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VERB Consumer Discretionary
  • OGEN Health Care
  • Exchange
  • VERB Nasdaq
  • OGEN Nasdaq
  • Market Cap
  • VERB 4.7M
  • OGEN 4.6M
  • IPO Year
  • VERB N/A
  • OGEN N/A
  • Fundamental
  • Price
  • VERB $4.31
  • OGEN $0.21
  • Analyst Decision
  • VERB Strong Buy
  • OGEN
  • Analyst Count
  • VERB 1
  • OGEN 0
  • Target Price
  • VERB $100.00
  • OGEN N/A
  • AVG Volume (30 Days)
  • VERB 33.5K
  • OGEN 357.6K
  • Earning Date
  • VERB 05-09-2025
  • OGEN 05-14-2025
  • Dividend Yield
  • VERB N/A
  • OGEN N/A
  • EPS Growth
  • VERB N/A
  • OGEN N/A
  • EPS
  • VERB N/A
  • OGEN N/A
  • Revenue
  • VERB $895,000.00
  • OGEN N/A
  • Revenue This Year
  • VERB $36.76
  • OGEN N/A
  • Revenue Next Year
  • VERB N/A
  • OGEN N/A
  • P/E Ratio
  • VERB N/A
  • OGEN N/A
  • Revenue Growth
  • VERB 1320.63
  • OGEN N/A
  • 52 Week Low
  • VERB $4.29
  • OGEN $0.19
  • 52 Week High
  • VERB $53.60
  • OGEN $3.43
  • Technical
  • Relative Strength Index (RSI)
  • VERB 36.22
  • OGEN 29.94
  • Support Level
  • VERB $4.51
  • OGEN $0.19
  • Resistance Level
  • VERB $4.99
  • OGEN $0.22
  • Average True Range (ATR)
  • VERB 0.54
  • OGEN 0.02
  • MACD
  • VERB -0.07
  • OGEN -0.01
  • Stochastic Oscillator
  • VERB 0.95
  • OGEN 20.43

About VERB Verb Technology Company Inc.

Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. Available in over 60 countries and in mobile and desktop versions, it includes verbLIVE an interactive livestream eCommerce, shoppable video and webinar, verbCRM a customer relationship management, verbTEAMS a self on-boarding version of verbCRM with built-in verbLIVE and salesforce synchronization for small businesses, verbLEARN a learning management system and among others.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Share on Social Networks: